Oracle Life Sciences Vice President of Global Innovation, Kathy Vandebelt, interviews industry experts and leaders on pressing topics in the Life Sciences industry.
All content for The Latest Dose is the property of Oracle Corporation and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Oracle Life Sciences Vice President of Global Innovation, Kathy Vandebelt, interviews industry experts and leaders on pressing topics in the Life Sciences industry.
Ep. 41: CancerX: Reducing incidence, burden, and disparities in cancer care
The Latest Dose
50 minutes 11 seconds
2 years ago
Ep. 41: CancerX: Reducing incidence, burden, and disparities in cancer care
The Latest Dose
Oracle Life Sciences Vice President of Global Innovation, Kathy Vandebelt, interviews industry experts and leaders on pressing topics in the Life Sciences industry.
